ProAssurance Reports Results for Second Quarter 2022
ProAssurance Corporation (NYSE: PRA) reported a net loss of $1.7 million or $0.03 per diluted share for Q2 2022, alongside an operating income of $16.3 million or $0.30 per diluted share. Key metrics included a 13% rise in gross premiums written to $235.5 million and a consolidated combined ratio of 102.9%, a slight improvement from Q1 2022. Net investment income increased by 26% to $22 million, though adjusted book value per share decreased to $25.96. The results show ongoing efforts in disciplined underwriting and strategic business initiatives post-NORCAL acquisition.
- Gross premiums written increased by 13% to $235.5 million.
- Net investment income rose by 26% to $22 million.
- Consolidated combined ratio improved to 102.9%, down 2.5 points from Q1 2022.
- Operating income increased by $8.6 million from Q1 2022.
- Net loss of $1.7 million compared to net income of $92 million in Q2 2021.
- Adjusted book value per share declined by $0.06 from Q1 2022.
- Operating income decreased by $10.3 million compared to Q2 2021.
Highlights - Second Quarter 2022(2)
-
Gross premiums written increased to
(+$235.5 million 13% ) and net premiums earned increased to (+$247 million 4% ) -
Favorable prior accident year reserve development of
(+$19 million 38% ) -
Consolidated combined ratio, excluding transaction-related costs, of
102.9% , down 2.5 points from first quarter 2022 and up 3.0 points from second quarter 2021 -
Net investment income increased to
(+$22 million 26% ) - Operating ROE(1) of 5.3 %, up 3.1 points from first quarter 2022 and down 2.7 points from second quarter 2021
-
Adjusted book value per share(1) of
, down$25.96 and$0.06 per share from$0.20 March 31, 2022 andDecember 31, 2021 , respectively
(1) |
Represents a Non-GAAP financial measure. See a reconciliation to its GAAP counterpart under the heading “Non-GAAP Financial Measures” that follows |
(2) |
Comparisons are to the second quarter of 2021 |
Management Commentary & Results of Operations
Our operating results for the second quarter of 2022 reflect continued improvement in underwriting results as we focus on disciplined underwriting and execute on our strategic business initiatives. Compared to the first quarter of 2022, our operating income improved
Consolidated gross premiums written increased
Net investment income increased due to the addition of NORCAL’s investment portfolio and the positive effect of rising interest rates; average book yields are beginning to increase as we reinvest maturing positions at higher rates. We expect the current rising interest rate environment to have a continued favorable impact on investment income prospectively.
Our book value per share of
CONSOLIDATED INCOME STATEMENT HIGHLIGHTS |
||||||||||||||||||||||||
Selected consolidated financial data for each period is summarized in the table below. |
||||||||||||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||||||||||||||
($ in thousands, except per share data) |
|
2022 |
|
|
|
2021 |
|
|
Change |
|
|
2022 |
|
|
|
2021 |
|
|
Change |
|||||
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Gross premiums written(1) |
$ |
235,475 |
|
|
$ |
208,509 |
|
|
|
12.9 |
% |
|
$ |
571,082 |
|
|
$ |
433,228 |
|
|
|
31.8 |
% |
|
Net premiums written |
$ |
210,151 |
|
|
$ |
188,214 |
|
|
|
11.7 |
% |
|
$ |
521,066 |
|
|
$ |
390,484 |
|
|
|
33.4 |
% |
|
Net premiums earned |
$ |
247,271 |
|
|
$ |
238,993 |
|
|
|
3.5 |
% |
|
$ |
512,982 |
|
|
$ |
426,351 |
|
|
|
20.3 |
% |
|
Net investment income |
|
21,944 |
|
|
|
17,417 |
|
|
|
26.0 |
% |
|
|
42,387 |
|
|
|
32,434 |
|
|
|
30.7 |
% |
|
Equity in earnings (loss) of unconsolidated subsidiaries |
|
5,180 |
|
|
|
11,927 |
|
|
|
(56.6 |
%) |
|
|
12,799 |
|
|
|
18,715 |
|
|
|
(31.6 |
%) |
|
Net investment gains (losses)(2) |
|
(23,884 |
) |
|
|
10,833 |
|
|
|
(320.5 |
%) |
|
|
(37,390 |
) |
|
|
19,682 |
|
|
|
(290.0 |
%) |
|
Other income(1) |
|
5,314 |
|
|
|
2,458 |
|
|
|
116.2 |
% |
|
|
8,119 |
|
|
|
4,462 |
|
|
|
82.0 |
% |
|
Total revenues(1) |
|
255,825 |
|
|
|
281,628 |
|
|
|
(9.2 |
%) |
|
|
538,897 |
|
|
|
501,644 |
|
|
|
7.4 |
% |
|
Expenses |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net losses and loss adjustment expenses |
|
177,670 |
|
|
|
181,852 |
|
|
|
(2.3 |
%) |
|
|
387,093 |
|
|
|
331,636 |
|
|
|
16.7 |
% |
|
Underwriting, policy acquisition and operating expenses(1) |
|
77,333 |
|
|
|
77,188 |
|
|
|
0.2 |
% |
|
|
149,109 |
|
|
|
133,638 |
|
|
|
11.6 |
% |
|
SPC |
|
349 |
|
|
|
504 |
|
|
|
(30.8 |
%) |
|
|
991 |
|
|
|
860 |
|
|
|
15.2 |
% |
|
SPC dividend expense (income) |
|
(854 |
) |
|
|
2,864 |
|
|
|
(129.8 |
%) |
|
|
1,513 |
|
|
|
4,606 |
|
|
|
(67.2 |
%) |
|
Interest expense |
|
4,919 |
|
|
|
5,176 |
|
|
|
(5.0 |
%) |
|
|
9,360 |
|
|
|
8,389 |
|
|
|
11.6 |
% |
|
Total expenses(1) |
|
259,417 |
|
|
|
267,584 |
|
|
|
(3.1 |
%) |
|
|
548,066 |
|
|
|
479,129 |
|
|
|
14.4 |
% |
|
Gain on bargain purchase |
|
— |
|
|
|
74,408 |
|
|
nm |
|
|
— |
|
|
|
74,408 |
|
|
nm |
|||||
Income (loss) before income taxes |
|
(3,592 |
) |
|
|
88,452 |
|
|
|
(104.1 |
%) |
|
|
(9,169 |
) |
|
|
96,923 |
|
|
|
(109.5 |
%) |
|
Income tax expense (benefit) |
|
(1,933 |
) |
|
|
(3,598 |
) |
|
|
46.3 |
% |
|
|
(3,950 |
) |
|
|
(2,862 |
) |
|
|
(38.0 |
%) |
|
Net income (loss) |
$ |
(1,659 |
) |
|
$ |
92,050 |
|
|
|
(101.8 |
%) |
|
$ |
(5,219 |
) |
|
$ |
99,785 |
|
|
|
(105.2 |
%) |
|
Non-GAAP operating income (loss) |
$ |
16,328 |
|
|
$ |
26,602 |
|
|
|
(38.6 |
%) |
|
$ |
24,008 |
|
|
$ |
28,688 |
|
|
|
(16.3 |
%) |
|
Weighted average number of common shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Basic |
|
54,068 |
|
|
|
53,965 |
|
|
|
|
|
54,040 |
|
|
|
53,942 |
|
|
|
|||||
Diluted |
|
54,186 |
|
|
|
54,048 |
|
|
|
|
|
54,165 |
|
|
|
54,023 |
|
|
|
|||||
Earnings (loss) per share |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net income (loss) per diluted share |
$ |
(0.03 |
) |
|
$ |
1.70 |
|
|
$ |
(1.73 |
) |
|
$ |
(0.10 |
) |
|
$ |
1.85 |
|
|
$ |
(1.95 |
) |
|
Non-GAAP operating income (loss) per diluted share |
$ |
0.30 |
|
|
$ |
0.49 |
|
|
$ |
(0.19 |
) |
|
$ |
0.44 |
|
|
$ |
0.53 |
|
|
$ |
(0.09 |
) |
(1) |
Consolidated totals include inter-segment eliminations. The eliminations affect individual line items only and have no effect on net income (loss). See Note 11 of the Notes to Condensed Consolidated Financial Statements in our |
(2) |
This line item typically includes both realized and unrealized investment gains and losses, as well as investment impairments. Detailed information regarding the components of net investment gains (losses) are included in Note 3 of the Notes to Condensed Consolidated Financial Statements in our |
The abbreviation “nm” indicates that the information or the percentage change is not meaningful. |
BALANCE SHEET HIGHLIGHTS |
||||||||
($ in thousands, except per share data) |
|
|
|
|||||
Total investments |
$ |
4,548,977 |
|
|
$ |
4,828,323 |
|
|
Total assets |
$ |
5,891,190 |
|
|
$ |
6,191,477 |
|
|
Total liabilities |
$ |
4,721,301 |
|
|
$ |
4,763,090 |
|
|
Common shares (par value |
$ |
634 |
|
|
$ |
633 |
|
|
Retained earnings |
$ |
1,423,865 |
|
|
$ |
1,434,491 |
|
|
|
$ |
(415,962 |
) |
|
$ |
(415,962 |
) |
|
Shareholders’ equity |
$ |
1,169,889 |
|
|
$ |
1,428,387 |
|
|
Book value per share |
$ |
21.63 |
|
|
$ |
26.46 |
|
|
Non-GAAP adjusted book value per share(1) |
$ |
25.96 |
|
|
$ |
26.16 |
|
(1) |
Adjusted book value per share is a Non-GAAP financial measure. See a reconciliation of book value per share to Non-GAAP adjusted book value per share under the heading “Non-GAAP Financial Measures” that follows. |
CONSOLIDATED KEY RATIOS |
||||||||||||
|
||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||
Current accident year net loss ratio |
79.5 |
% |
|
81.9 |
% |
|
80.2 |
% |
|
82.2 |
% |
|
Effect of prior accident years’ reserve development |
(7.6 |
%) |
|
(5.8 |
%) |
|
(4.7 |
%) |
|
(4.4 |
%) |
|
Net loss ratio |
71.9 |
% |
|
76.1 |
% |
|
75.5 |
% |
|
77.8 |
% |
|
Underwriting expense ratio(2) |
31.3 |
% |
|
32.3 |
% |
|
29.1 |
% |
|
31.3 |
% |
|
Combined ratio |
103.2 |
% |
|
108.4 |
% |
|
104.6 |
% |
|
109.1 |
% |
|
Operating ratio |
94.3 |
% |
|
101.1 |
% |
|
96.3 |
% |
|
101.5 |
% |
|
Return on equity(1) |
(0.4 |
%) |
|
9.0 |
% |
|
(0.7 |
%) |
|
5.0 |
% |
|
Non-GAAP return on equity(1)(2) |
5.3 |
% |
|
8.0 |
% |
|
3.7 |
% |
|
4.3 |
% |
|
|
|
|
|
|
|
|
|
|||||
Combined ratio, excluding transaction-related costs(3) |
102.9 |
% |
|
99.9 |
% |
|
104.3 |
% |
|
104.2 |
% |
(1) |
Quarterly amounts are annualized. Refer to our |
(2) |
See a reconciliation of ROE to Non-GAAP ROE under the heading “Non-GAAP Financial Measures” that follows. |
(3) |
Our consolidated underwriting expense ratios for three and six months ended |
SPECIALTY P&C SEGMENT RESULTS |
||||||||||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||||||||||||
($ in thousands) |
|
2022 |
|
|
|
2021 |
|
|
% Change |
|
|
2022 |
|
|
|
2021 |
|
|
% Change |
|||
Gross premiums written |
$ |
167,760 |
|
|
$ |
142,035 |
|
|
18.1 |
% |
|
$ |
425,433 |
|
|
$ |
280,323 |
|
|
51.8 |
% |
|
Net premiums written |
$ |
150,015 |
|
|
$ |
127,434 |
|
|
17.7 |
% |
|
$ |
384,853 |
|
|
$ |
248,747 |
|
|
54.7 |
% |
|
Net premiums earned |
$ |
183,547 |
|
|
$ |
168,635 |
|
|
8.8 |
% |
|
$ |
381,514 |
|
|
$ |
284,249 |
|
|
34.2 |
% |
|
Other income |
|
1,903 |
|
|
|
1,471 |
|
|
29.4 |
% |
|
|
2,924 |
|
|
|
1,939 |
|
|
50.8 |
% |
|
Total revenues |
|
185,450 |
|
|
|
170,106 |
|
|
9.0 |
% |
|
|
384,438 |
|
|
|
286,188 |
|
|
34.3 |
% |
|
Net losses and loss adjustment expenses |
|
(137,002 |
) |
|
|
(140,214 |
) |
|
(2.3 |
%) |
|
|
(302,960 |
) |
|
|
(241,400 |
) |
|
25.5 |
% |
|
Underwriting, policy acquisition and operating expenses |
|
(48,077 |
) |
|
|
(28,877 |
) |
|
66.5 |
% |
|
|
(90,958 |
) |
|
|
(55,223 |
) |
|
64.7 |
% |
|
Total expenses |
|
(185,079 |
) |
|
|
(169,091 |
) |
|
9.5 |
% |
|
|
(393,918 |
) |
|
|
(296,623 |
) |
|
32.8 |
% |
|
Segment results |
$ |
371 |
|
|
$ |
1,015 |
|
|
(63.4 |
%) |
|
$ |
(9,480 |
) |
|
$ |
(10,435 |
) |
|
9.2 |
% |
SPECIALTY P&C SEGMENT KEY RATIOS |
||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||
Current accident year net loss ratio |
84.1 |
% |
|
89.4 |
% |
|
85.0 |
% |
|
89.6 |
% |
|
Effect of prior accident years’ reserve development |
(9.5 |
%) |
|
(6.3 |
%) |
|
(5.6 |
%) |
|
(4.7 |
%) |
|
Net loss ratio |
74.6 |
% |
|
83.1 |
% |
|
79.4 |
% |
|
84.9 |
% |
|
Underwriting expense ratio |
26.2 |
% |
|
17.1 |
% |
|
23.8 |
% |
|
19.4 |
% |
|
Combined ratio |
100.8 |
% |
|
100.2 |
% |
|
103.2 |
% |
|
104.3 |
% |
The positive segment result in the quarter reflects continued improvement in operating performance and includes the effect of certain purchase accounting adjustments. Segment results were driven by lower accident and calendar year loss ratios, diligent focus on re-underwriting, prudent expense management, and continued discipline in the execution of the NORCAL integration plan.
The top line increase in premium is related to the NORCAL acquisition which closed in May of 2021. Gross written premiums increased
Overall, the segment’s premium retention in the quarter was
The current accident year loss ratio improved 5.3 percentage points driven primarily by a 2.4 point improvement in the NORCAL book. Overall, we continue to observe lower claims frequency in our healthcare liability business, which we believe is attributable to a combination of our underwriting efforts and the pandemic. We continue to remain cautious in recognizing the full impact of this trend in our current accident year loss estimate due to the long-tailed nature of our Healthcare Liability claims and the uncertainty of the pandemic impact.
We recognized net favorable prior accident year reserve development of
The expense ratio in the second quarter of 2022 was
Refer to our
WORKERS’ COMPENSATION INSURANCE SEGMENT RESULTS |
||||||||||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||||||||||||
($ in thousands) |
|
2022 |
|
|
|
2021 |
|
|
% Change |
|
|
2022 |
|
|
|
2021 |
|
|
% Change |
|||
Gross premiums written |
$ |
63,634 |
|
|
$ |
57,845 |
|
|
10.0 |
% |
|
$ |
135,752 |
|
|
$ |
130,173 |
|
|
4.3 |
% |
|
Net premiums written |
$ |
42,558 |
|
|
$ |
40,784 |
|
|
4.3 |
% |
|
$ |
87,824 |
|
|
$ |
87,668 |
|
|
0.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net premiums earned |
$ |
41,709 |
|
|
$ |
40,626 |
|
|
2.7 |
% |
|
$ |
82,393 |
|
|
$ |
80,636 |
|
|
2.2 |
% |
|
Other income |
|
517 |
|
|
|
900 |
|
|
(42.6 |
%) |
|
|
1,199 |
|
|
|
1,293 |
|
|
(7.3 |
%) |
|
Total revenues |
|
42,226 |
|
|
|
41,526 |
|
|
1.7 |
% |
|
|
83,592 |
|
|
|
81,929 |
|
|
2.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net losses and loss adjustment expenses |
|
(27,947 |
) |
|
|
(27,751 |
) |
|
0.7 |
% |
|
|
(55,158 |
) |
|
|
(53,958 |
) |
|
2.2 |
% |
|
Underwriting, policy acquisition and operating expenses |
|
(13,669 |
) |
|
|
(12,712 |
) |
|
7.5 |
% |
|
|
(26,669 |
) |
|
|
(24,998 |
) |
|
6.7 |
% |
|
Total expenses |
|
(41,616 |
) |
|
|
(40,463 |
) |
|
2.8 |
% |
|
|
(81,827 |
) |
|
|
(78,956 |
) |
|
3.6 |
% |
|
Segment results |
$ |
610 |
|
|
$ |
1,063 |
|
|
(42.6 |
%) |
|
$ |
1,765 |
|
|
$ |
2,973 |
|
|
(40.6 |
%) |
WORKERS’ COMPENSATION INSURANCE SEGMENT KEY RATIOS |
||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||
Current accident year net loss ratio |
71.8 |
% |
|
73.0 |
% |
|
71.8 |
% |
|
72.0 |
% |
|
Effect of prior accident years’ reserve development |
(4.8 |
%) |
|
(4.7 |
%) |
|
(4.9 |
%) |
|
(5.1 |
%) |
|
Net loss ratio |
67.0 |
% |
|
68.3 |
% |
|
66.9 |
% |
|
66.9 |
% |
|
Underwriting expense ratio |
32.8 |
% |
|
31.3 |
% |
|
32.4 |
% |
|
31.0 |
% |
|
Combined ratio |
99.8 |
% |
|
99.6 |
% |
|
99.3 |
% |
|
97.9 |
% |
The Workers’
Gross premiums written increased during the three months ended
The net loss ratio improved to
The increase in the underwriting expense ratio in the second quarter of 2022 primarily reflects higher compensation-related costs from filling open positions and an increase in travel-related costs associated with the easing of pandemic-related restrictions and the return to more normal business-related activities.
SEGREGATED PORTFOLIO CELL REINSURANCE SEGMENT RESULTS |
||||||||||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||||||||||||
($ in thousands) |
|
2022 |
|
|
|
2021 |
|
|
% Change |
|
|
2022 |
|
|
|
2021 |
|
|
% Change |
|||
Gross premiums written |
$ |
16,634 |
|
|
$ |
16,060 |
|
|
3.6 |
% |
|
$ |
45,003 |
|
|
$ |
41,211 |
|
|
9.2 |
% |
|
Net premiums written |
$ |
14,515 |
|
|
$ |
14,208 |
|
|
2.2 |
% |
|
$ |
39,732 |
|
|
$ |
36,396 |
|
|
9.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net premiums earned |
$ |
16,222 |
|
|
$ |
16,272 |
|
|
(0.3 |
%) |
|
$ |
35,536 |
|
|
$ |
32,156 |
|
|
10.5 |
% |
|
Net investment income |
|
211 |
|
|
|
206 |
|
|
2.4 |
% |
|
|
323 |
|
|
|
427 |
|
|
(24.4 |
%) |
|
Net investment gains (losses) |
|
(2,782 |
) |
|
|
1,580 |
|
|
(276.1 |
%) |
|
|
(3,493 |
) |
|
|
2,568 |
|
|
(236.0 |
%) |
|
Other income |
|
1 |
|
|
|
1 |
|
|
0.0 |
% |
|
|
1 |
|
|
|
2 |
|
|
(50.0 |
%) |
|
Net losses and loss adjustment expenses |
|
(9,272 |
) |
|
|
(8,443 |
) |
|
9.8 |
% |
|
|
(20,763 |
) |
|
|
(17,867 |
) |
|
16.2 |
% |
|
Underwriting, policy acquisition and operating expenses |
|
(5,237 |
) |
|
|
(5,293 |
) |
|
(1.1 |
%) |
|
|
(9,605 |
) |
|
|
(10,320 |
) |
|
(6.9 |
%) |
|
SPC |
|
(349 |
) |
|
|
(504 |
) |
|
(30.8 |
%) |
|
|
(991 |
) |
|
|
(860 |
) |
|
15.2 |
% |
|
SPC net results |
|
(1,206 |
) |
|
|
3,819 |
|
|
(131.6 |
%) |
|
|
1,008 |
|
|
|
6,106 |
|
|
(83.5 |
%) |
|
SPC dividend (expense) income (2) |
|
854 |
|
|
|
(2,864 |
) |
|
(129.8 |
%) |
|
|
(1,513 |
) |
|
|
(4,606 |
) |
|
(67.2 |
%) |
|
Segment results (3) |
$ |
(352 |
) |
|
$ |
955 |
|
|
(136.9 |
%) |
|
$ |
(505 |
) |
|
$ |
1,500 |
|
|
(133.7 |
%) |
(1) |
Represents the provision for |
(2) |
Represents the net (profit) loss attributable to external cell participants. |
(3) |
Represents our share of the net profit (loss) and OCI of the SPCs in which we participate. |
SEGREGATED PORTFOLIO CELL REINSURANCE SEGMENT KEY RATIOS |
||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||
Current accident year net loss ratio |
70.7 |
% |
|
62.9 |
% |
|
67.3 |
% |
|
65.8 |
% |
|
Effect of prior accident years’ reserve development |
(13.5 |
%) |
|
(11.0 |
%) |
|
(8.9 |
%) |
|
(10.2 |
%) |
|
Net loss ratio |
57.2 |
% |
|
51.9 |
% |
|
58.4 |
% |
|
55.6 |
% |
|
Underwriting expense ratio |
32.3 |
% |
|
32.5 |
% |
|
27.0 |
% |
|
32.1 |
% |
|
Combined ratio |
89.5 |
% |
|
84.4 |
% |
|
85.4 |
% |
|
87.7 |
% |
The Segregated Portfolio Cell Reinsurance segment result decreased in the second quarter of 2022 compared to the same period in 2021, primarily reflecting an increase in the calendar year net loss ratio and the decline in the equity and fixed income markets.
Gross premiums written increased during the three months ended
Audit premium billed to policyholders increased
The net loss ratio increased to
The underwriting expense ratio was relatively consistent from 2021 to 2022. Underwriting expenses primarily reflect commissions and other expenses charged by the Workers’
LLOYD’S SYNDICATES SEGMENT RESULTS |
||||||||||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||||||||||||
($ in thousands) |
|
2022 |
|
|
|
2021 |
|
|
% Change |
|
|
2022 |
|
|
|
2021 |
|
|
% Change |
|||
Gross premiums written |
$ |
4,081 |
|
|
$ |
8,629 |
|
|
(52.7 |
%) |
|
$ |
9,897 |
|
|
$ |
22,732 |
|
|
(56.5 |
%) |
|
Net premiums written |
$ |
3,063 |
|
|
$ |
5,788 |
|
|
(47.1 |
%) |
|
$ |
8,657 |
|
|
$ |
17,673 |
|
|
(51.0 |
%) |
|
Net premiums earned |
$ |
5,793 |
|
|
$ |
13,460 |
|
|
(57.0 |
%) |
|
$ |
13,539 |
|
|
$ |
29,310 |
|
|
(53.8 |
%) |
|
Net investment income |
|
143 |
|
|
|
518 |
|
|
(72.4 |
%) |
|
|
355 |
|
|
|
1,246 |
|
|
(71.5 |
%) |
|
Net investment gains (losses) |
|
(485 |
) |
|
|
89 |
|
|
(644.9 |
%) |
|
|
(884 |
) |
|
|
(26 |
) |
|
3,300.0 |
% |
|
Other income (loss) |
|
129 |
|
|
|
361 |
|
|
(64.3 |
%) |
|
|
263 |
|
|
|
582 |
|
|
(54.8 |
%) |
|
Net losses and loss adjustment expenses |
|
(3,449 |
) |
|
|
(5,444 |
) |
|
(36.6 |
%) |
|
|
(8,212 |
) |
|
|
(18,411 |
) |
|
(55.4 |
%) |
|
Underwriting, policy acquisition and operating expenses |
|
(1,508 |
) |
|
|
(4,721 |
) |
|
(68.1 |
%) |
|
|
(4,218 |
) |
|
|
(11,311 |
) |
|
(62.7 |
%) |
|
Segment results |
$ |
623 |
|
|
$ |
4,263 |
|
|
(85.4 |
%) |
|
$ |
843 |
|
|
$ |
1,390 |
|
|
(39.4 |
%) |
LLOYD’S SYNDICATES SEGMENT KEY RATIOS |
||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||
Current accident year net loss ratio |
14.1 |
% |
|
37.2 |
% |
|
29.9 |
% |
|
56.1 |
% |
|
Effect of prior accident years’ reserve development |
45.4 |
% |
|
3.2 |
% |
|
30.8 |
% |
|
6.7 |
% |
|
Net loss ratio |
59.5 |
% |
|
40.4 |
% |
|
60.7 |
% |
|
62.8 |
% |
|
Underwriting expense ratio |
26.0 |
% |
|
35.1 |
% |
|
31.2 |
% |
|
38.6 |
% |
|
Combined ratio |
85.5 |
% |
|
75.5 |
% |
|
91.9 |
% |
|
101.4 |
% |
Results of our Lloyd’s Syndicates segment are generally reported on a one-quarter lag and include the results from our current participation in Lloyd's of London Syndicate 1729 (
Net premiums earned from our Lloyd’s Syndicates segment declined to
CORPORATE SEGMENT |
||||||||||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||||||||||||
($ in thousands) |
|
2022 |
|
|
|
2021 |
|
|
% Change |
|
|
2022 |
|
|
|
2021 |
|
|
% Change |
|||
Net investment income |
$ |
21,590 |
|
|
$ |
16,693 |
|
|
29.3 |
% |
|
$ |
41,709 |
|
|
$ |
30,761 |
|
|
35.6 |
% |
|
Equity in earnings (loss) of unconsolidated subsidiaries: |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
All other investments, primarily investment fund LPs/LLCs |
|
7,028 |
|
|
|
16,680 |
|
|
(57.9 |
%) |
|
|
17,035 |
|
|
|
26,654 |
|
|
(36.1 |
%) |
|
Tax credit partnerships |
|
(1,848 |
) |
|
|
(4,753 |
) |
|
(61.1 |
%) |
|
|
(4,236 |
) |
|
|
(7,939 |
) |
|
(46.6 |
%) |
|
Total equity in earnings (loss) of unconsolidated subsidiaries: |
|
5,180 |
|
|
|
11,927 |
|
|
(56.6 |
%) |
|
|
12,799 |
|
|
|
18,715 |
|
|
(31.6 |
%) |
|
Net investment gains (losses) |
|
(20,617 |
) |
|
|
9,164 |
|
|
(325.0 |
%) |
|
|
(33,013 |
) |
|
|
17,140 |
|
|
(292.6 |
%) |
|
Other income |
|
3,626 |
|
|
|
351 |
|
|
933.0 |
% |
|
|
5,691 |
|
|
|
2,245 |
|
|
153.5 |
% |
|
Operating expenses |
|
(9,019 |
) |
|
|
(5,929 |
) |
|
52.1 |
% |
|
|
(17,756 |
) |
|
|
(12,177 |
) |
|
45.8 |
% |
|
Interest expense |
|
(4,919 |
) |
|
|
(5,176 |
) |
|
(5.0 |
%) |
|
|
(9,360 |
) |
|
|
(8,389 |
) |
|
11.6 |
% |
|
Income tax (expense) benefit |
|
1,789 |
|
|
|
(220 |
) |
|
(913.2 |
%) |
|
|
3,559 |
|
|
|
(1,151 |
) |
|
(409.2 |
%) |
|
Segment results |
$ |
(2,370 |
) |
|
$ |
26,810 |
|
|
(108.8 |
%) |
|
$ |
3,629 |
|
|
$ |
47,144 |
|
|
(92.3 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Consolidated effective tax rate |
|
53.8 |
% |
|
|
(4.1 |
%) |
|
|
|
|
43.1 |
% |
|
|
(3.0 |
%) |
|
|
Our Corporate segment results for the second quarter of 2022 continue to reflect the challenging investment environment, where rising interest rates led to
Equity in earnings of our unconsolidated subsidiaries decreased
Other income increased during the quarter driven by the effect of foreign currency exchange rate changes of
Operating expenses increased
Non-GAAP Financial Measures
Non-GAAP Operating Income (Loss)
Non-GAAP operating income (loss) is a financial measure that is widely used to evaluate performance within the insurance sector. In calculating Non-GAAP operating income (loss), we have excluded the effects of the items listed in the following table that do not reflect normal results. We believe Non-GAAP operating income (loss) presents a useful view of the performance of our insurance operations, however it should be considered in conjunction with net income (loss) computed in accordance with GAAP. The following table reconciles net income (loss) to Non-GAAP operating income (loss):
RECONCILIATION OF NET INCOME (LOSS) TO NON-GAAP OPERATING INCOME (LOSS) |
||||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
|||||||||||||
(In thousands, except per share data) |
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
Net income (loss) |
$ |
(1,659 |
) |
|
$ |
92,050 |
|
|
$ |
(5,219 |
) |
|
$ |
99,785 |
|
|
Items excluded in the calculation of Non-GAAP operating income (loss): |
|
|
|
|
|
|
|
|||||||||
Net investment (gains) losses |
|
23,884 |
|
|
|
(10,833 |
) |
|
|
37,390 |
|
|
|
(19,682 |
) |
|
Net investment gains (losses) attributable to SPCs which no profit/loss is retained (1) |
|
(2,198 |
) |
|
|
1,275 |
|
|
|
(2,800 |
) |
|
|
2,065 |
|
|
Transaction-related costs (2) |
|
685 |
|
|
|
20,282 |
|
|
|
1,862 |
|
|
|
21,208 |
|
|
Guaranty fund assessments (recoupments) |
|
113 |
|
|
|
130 |
|
|
|
125 |
|
|
|
133 |
|
|
Gain on bargain purchase (3) |
|
— |
|
|
|
(74,408 |
) |
|
|
— |
|
|
|
(74,408 |
) |
|
Pre-tax effect of exclusions |
|
22,484 |
|
|
|
(63,554 |
) |
|
|
36,577 |
|
|
|
(70,684 |
) |
|
Tax effect, at |
|
(4,497 |
) |
|
|
(1,894 |
) |
|
|
(7,350 |
) |
|
|
(413 |
) |
|
After-tax effect of exclusions |
|
17,987 |
|
|
|
(65,448 |
) |
|
|
29,227 |
|
|
|
(71,097 |
) |
|
Non-GAAP operating income (loss) |
$ |
16,328 |
|
|
$ |
26,602 |
|
|
$ |
24,008 |
|
|
$ |
28,688 |
|
|
Per diluted common share: |
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
$ |
(0.03 |
) |
|
$ |
1.70 |
|
|
$ |
(0.10 |
) |
|
$ |
1.85 |
|
|
Effect of exclusions |
|
0.33 |
|
|
|
(1.21 |
) |
|
|
0.54 |
|
|
|
(1.32 |
) |
|
Non-GAAP operating income (loss) per diluted common share |
$ |
0.30 |
|
|
$ |
0.49 |
|
|
$ |
0.44 |
|
|
$ |
0.53 |
|
(1) |
Net investment gains (losses) on investments related to SPCs are recognized in our Segregated Portfolio Cell Reinsurance segment. SPC results, including any net investment gain or loss, that are attributable to external cell participants are reflected in the SPC dividend expense (income). To be consistent with our exclusion of net investment gains (losses) recognized in earnings, we are excluding the portion of net investment gains (losses) that is included in the SPC dividend expense (income) which is attributable to the external cell participants. |
(2) |
Transaction-related costs associated with our acquisition of NORCAL. We are excluding these costs as they do not reflect normal operating results and are unique and non-recurring in nature. |
(3) |
Gain on bargain purchase associated with our acquisition of NORCAL which is considered unusual, infrequent and non-recurring in nature. As such, we have excluded the gain on bargain purchase from Non-GAAP operating income (loss) as it does not reflect normal operating results. |
(4) |
The |
Non-GAAP Operating ROE
The following table is a reconciliation of ROE to Non-GAAP operating ROE for the three and six months ended
|
Three Months Ended
|
|
Six Months Ended
|
|||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||
ROE(1) |
(0.4 |
%) |
|
9.0 |
% |
|
(0.7 |
%) |
|
5.0 |
% |
|
Pre-tax effect of items excluded in the calculation of Non-GAAP operating ROE |
7.2 |
% |
|
(0.4 |
%) |
|
5.5 |
% |
|
(0.6 |
%) |
|
Tax effect, at |
(1.5 |
%) |
|
(0.6 |
%) |
|
(1.1 |
%) |
|
(0.1 |
%) |
|
Non-GAAP operating ROE |
5.3 |
% |
|
8.0 |
% |
|
3.7 |
% |
|
4.3 |
% |
(1) |
Quarterly amounts are annualized. Refer to our |
(2) |
The |
Non-GAAP Adjusted Book Value per Share
The following table is a reconciliation of our book value per share to Non-GAAP adjusted book value per share at
|
Book Value Per Share |
|||
Book Value Per Share at |
$ |
26.46 |
|
|
Less: AOCI Per Share |
|
0.30 |
|
|
Non-GAAP Adjusted Book Value Per Share at |
|
26.16 |
|
|
Increase (decrease) to Adjusted Book Value Per Share during the six months ended |
|
|||
Dividends declared |
|
(0.10 |
) |
|
Net income (loss) |
|
(0.10 |
) |
|
Non-GAAP Adjusted Book Value Per Share at |
$ |
25.96 |
|
|
Add: AOCI Per Share |
|
(4.33 |
) |
|
Book Value Per Share at |
$ |
21.63 |
|
Conference Call Information
A replay will be available by telephone through at least
About
Caution Regarding Forward-Looking Statements
Any statements in this news release that are not historical facts are specifically identified as forward-looking statements. These statements are based upon our estimates and anticipation of future events and are subject to significant risks, assumptions and uncertainties that could cause actual results to differ materially from the expected results described in the forward-looking statements. Forward-looking statements are identified by words such as, but not limited to, “anticipate,” “believe,” “estimate,” “expect,” “hope,” “hopeful,” “intend,” “likely,” “may,” “optimistic,” “possible,” “potential,” “preliminary,” “project,” “should,” “will,” and other analogous expressions.
Although it is not possible to identify all of these risks and factors, they include, among others, the following: inadequate loss reserves to cover the Company's actual losses; inherent uncertainty of models resulting in actual losses that are materially different than the Company's estimates; adverse economic factors; a decline in the Company's financial strength rating; loss of one or more key executives; loss of a group of agents or brokers that generate significant portions of the Company's business; failure of any of the loss limitations or exclusions the Company employs, or change in other claims or coverage issues; adverse performance of the Company's investment portfolio; adverse market conditions that affect its excess and surplus lines insurance operations; and other risks described in the Company's filings with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20220808005714/en/
VP, Investor Relations
800-282-6242 • 512-879-5101 • JasonGingerich@ProAssurance.com
Source:
FAQ
What were ProAssurance's earnings per share for Q2 2022?
How much did gross premiums written increase in Q2 2022 for PRA?
What is the consolidated combined ratio for ProAssurance in Q2 2022?
What was the net investment income for ProAssurance in Q2 2022?